✦ LIBER ✦

All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses

✍ Scribed by Hagan, L. M.; Yang, Z.; Ehteshami, M.; Schinazi, R. F.

Book ID: 120508391
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 237 KB
Volume: 20
Category: Article
ISSN: 1352-0504
DOI: 10.1111/jvh.12111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of treatment for chro

Cost-effectiveness of treatment for chronic hepatitis C

✍ Raymond S. Koff 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Sa1067 Interferon-Based and Interferon-F

Sa1067 Interferon-Based and Interferon-Free Regimens for Patients With Chronic Hepatitis C, Genotype 1: Potential Cost-Effectiveness of Biopsy-Guided Treatment Versus Treat All Strategies

✍ Younossi, Zobair M.; Singer, Mendel E.; Mir, Heshaam M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 363 KB

Cost-effectiveness of oral treatments fo

Cost-effectiveness of oral treatments for chronic hepatitis B

✍ Geoffrey M. Dusheiko 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Cost-effectiveness of treatments for chr

Cost-effectiveness of treatments for chronic hepatitis C

✍ John B Wong 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 223 KB

The cost-effectiveness of prolonged alfa

The cost-effectiveness of prolonged alfa interferon for chronic hepatitis C in Spain

✍ M. Buti; M.A. Casado; L. Fosbrook; R. Esteban 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Cost effectiveness of interferon α2b com

Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis C

✍ Zobair M. Younossi; Mendel E. Singer; John G. McHutchison; Kenneth M. Shermock 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Treatment of chronic hepatitis C with Interferon (IFN) ␣2b monotherapy results in 10% to 15% sustained virological response (SVR). Combining IFN with ribavirin increases this response. In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C (previously untreated